Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: iminosugar antivirals - United Therapeutics

Drug Profile

Research programme: iminosugar antivirals - United Therapeutics

Alternative Names: EBI 001; Glycobiology antiviral agents; Iminosugar antivirals - United Therapeutics

Latest Information Update: 04 Jun 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Synergy Pharmaceuticals; University of Oxford
  • Developer Emergent BioSolutions
  • Class Antivirals; Imino sugars; Small molecules
  • Mechanism of Action Glucosidase inhibitors; Hepatitis B virus replication inhibitors; Virus replication inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Influenza virus infections
  • Discontinued Encephalitis virus infections; Hepatitis B

Most Recent Events

  • 04 Jun 2018 Discontinued - Preclinical for Encephalitis virus infections in USA (PO)
  • 04 Jun 2018 Discontinued - Preclinical for Hepatitis B in USA (PO)
  • 04 Jun 2018 Discontinued - Preclinical for Hepatitis C in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top